What You Should Know:
– Parakeet Health, a generative AI company focused on patient engagement, announced new partnerships with Aegis Medical Group and Schweiger Dermatology Group.
– The company’s generative AI-powered platform replaces traditional bottlenecks and…
Continue Reading
This systematic review synthesized 61 dynamically tailored eHealth interventions for chronic disease management from 117 papers. Tailoring strategies varied in scope and complexity, with most targeting physical activity (87%) and nutrition (43%), while nearly…
Continue Reading
Critics have questioned the objectivity of medical journal editors and peer reviewers, asking whether these “watchers” are preventing the best innovations from reaching professional readers.
By John Halamka, M.D., Diercks President, Mayo Clinic Platform and…
Continue Reading
It’s a common refrain in hospitals, health systems and other enterprises: As technology increases in popularity and usefulness, the sprawl that ensues makes management and governance more difficult. In that sense, artificial intelligence tools…
Continue Reading
Facial palsy, affecting 1 in 60 individuals, requires precise assessment for effective treatment and follow-up. Current grading systems are inconsistent due to redundant subjective factors. Discrete assessment of the whole face fails to address…
Continue Reading
News
[embedded content]
Google releases Gemini 3 and Google Antigravity, a new agentic AI development platform.
Microsoft announces Agent 365, which helps enterprises deploy, organize, and govern agents that are developed internally or provided by…
[embedded content]
What You Should Know:
– Arbiter, a new AI-powered care orchestration platform, has launched from stealth with $52M in funding, led by TriEdge Investments and MFO Ventures, to unite payers, providers, and patients and…
Continue Reading
What You Should Know:
– Ember, the AI-native solution for denial prevention secures $4.3M in seed funding round led by Nexus Venture Partners and Y Combinator.
– Its platform uses deep knowledge of payer policies to…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
Dr Henrietta Hughes OBE, England’s patient safety commissioner (Credit: Photographs by Photographer London)
A new commission will help ensure that the UK’s regulatory system can cope with AI, writes Henrietta Hughes, patient safety commissioner…
Continue Reading
